![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Press Releases
Oxford Medical Diagnostics and V&F join forces in the field of mass spectrometry
Oxford Medical Diagnostics (OMD), the UK developer of breath based, medical diagnostic technology for the rapid, non-invasive, accurate and low-cost diagnosis and monitoring of...
Press Releases
Nycomed’s novel COPD therapy roflumilast receives FDA approval
Nycomed’s US partner Forest Laboratories, Inc.announced that DalirespTM (roflumilast) was approved by the US Food and Drug Administration (FDA) as a treatment to reduce...
Press Releases
PharmaDiagnostics appoints director of assay development
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized instrumentation, announces today the appointment of...
Press Releases
Apricus Biosciences Announced European Patient Coverage For Mycova For Nail Fungus
Apricus Biosciences, Inc. announced that the European Patent Office will grant a patent for the company's MycoVa™ product for treating onychomycosis (commonly referred to...
Press Releases
Patent plethora in 2010 breaks record for Biocitech technology park residents
Biocitech SAS, the Paris life science technology park, today announced that its 25 resident companies applied for a bumper number of patents with a...
Press Releases
Trophos successfully completes phase 1 study for novel cardioprotective compound, TRO40303
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology,...
Press Releases
Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Rasilamlo(TM) (aliskiren and amlodipine) to treat high...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read